TY  - JOUR
T1  - Status, quality and specific needs of Zika virus (ZIKV) diagnostic capacity and capability in National Reference Laboratories for arboviruses in 30 EU/EEA countries, May 2016
AU  - Mögling, Ramona
AU  - Zeller, Hervé
AU  - Revez, Joana
AU  - Koopmans, Marion
AU  - ZIKV reference laboratory group
AU  - Reusken, Chantal
AU  - Aberle, Stephan
AU  - van Esbroeck, Marjan
AU  - Christova, Iva
AU  - Vilibic-Cavlek, Tatjana
AU  - Richter, Jan
AU  - Zelena, Hana
AU  - Fomsgaard, Anders
AU  - Peetso, Rita
AU  - Jääskeläinen, Anne J.
AU  - Brichler, Segolene
AU  - Jirincova, Helena
AU  - Bigailoon, Christine
AU  - Illiaquer, Marina
AU  - Gaba, Salim
AU  - Gonfier, Geraldine
AU  - Ramière, Christophe
AU  - Poveda, Jean-Domnique
AU  - Fafi-Kremer, Samira
AU  - Foulongne, V.
AU  - Henquell, Cécile
AU  - Leveque, Nicolas
AU  - Carles, Marie Josee
AU  - Mansuy, J. M.
AU  - Schmidt-Chanasit, Jonas
AU  - Nitsche, Andreas
AU  - Papa, Anna
AU  - Mentis, Andreas
AU  - Takács, Mária
AU  - Löve, Arthur
AU  - COnell, Jeff
AU  - Venturi, Giulietta
AU  - Storoženko, Jelena
AU  - Griskevicius, Algirdas
AU  - Opp, Matthias
AU  - Barbara, Christopher
AU  - Reimerink, Johan
AU  - Gjeruldsen, Susanne
AU  - Pancer, Katarzyna
AU  - João Alves, Maria
AU  - Ceianu, Cornelia S.
AU  - Tichá, Elena
AU  - Avšič Županc, Tatjana
AU  - Sanchez-Seco, Maria Paz
AU  - Tolfvenstam, Thomas
AU  - Aarons, Emma
AB  - With international travel, Zika virus (ZIKV) is introduced to Europe regularly. A country's ability to robustly detect ZIKV introduction and local transmission is important to minimise the risk for a ZIKV outbreak. Therefore, sufficient expertise and diagnostic capacity and capability are required in European laboratories. To assess the capacity, quality, operational specifics (guidelines and algorithms), technical and interpretation issues and other possible difficulties that were related to ZIKV diagnostics in European countries, a questionnaire was conducted among national reference laboratories in 30 countries in the European Union/European Economic Area (EU/EEA) in May 2016. While the coverage and capacity of ZIKV diagnostics in the EU/EEA national reference laboratories were found to be adequate, the assessment of the quality and needs indicated several crucial points of improvement that will need support at national and EU/EEA level to improve ZIKV preparedness, response and EU/EEA ZIKV surveillance activities.
KW  - 610 Medizin und Gesundheit
PY  - 2017
LA  - eng
PB  - Robert Koch-Institut
JO  - Eurosurveilance
VL  - 22
IS  - 36
DO  - 10.2807/1560-7917.ES.2017.22.36.30609
ER  -